Duration: 1 hour
Sepsis remains a leading cause of death in America, with over 258,000 deaths annually and over 160,000 of those occurring in hospitals. In August 2016, the Centers for Disease Control and Prevention declared that sepsis is a medical emergency. This educational webinar will focus on the importance of point-of-care (POC) and critical care testing in the early identification, evaluation, and continued diagnostic support required for the management of patients with sepsis. Dr. Ntrivalas will review the value of rapid lactate testing, laboratory diagnostic imperatives including monitoring for electrolyte imbalances, and the role of magnesium in sepsis management.
- Review the role of POC diagnostics for rapid identification, treatment, and monitoring of sepsis and other stressor states.
- Differentiate between POC and central laboratory lactate testing in the management of sepsis.
- Describe why rapid ionized magnesium is a critical piece of the electrolyte profile in critical care medicine.
This webinar provides 1 contact hour for P.A.C.E. continuing education credits. Nova Biomedical is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. program. P.A.C.E. is a registered trademark of the American Society for Clinical Laboratory Science.
This program has been approved by the American Association of Critical-Care Nurses (AACN) for 1.00 Synergy CERPs Category A. Speakers
Evan Ntrivalas, MD, PhD
Director of Medical & Scientific Affairs
Dr. Ntrivalas received his M.D. from Medical School, University of Thessaloniki, Greece, and his Ph.D. in Microbiology and Immunology from Rosalind Franklin University of Medicine and Science (RFUMS), North Chicago, IL. He then completed a Clinical Immunology Fellowship and subsequently became the Assistant Director in the Clinical Immunology Laboratory at RFUMS. He then moved to Scarborough, Maine, where he became the Clinical Laboratory Director at the Foundation for Blood Research.
Dr. Ntrivalas is a board-certified Clinical Laboratory Director. He is board-certified through the American Board of Medical Laboratory Immunology (D(ABMLI)) and through the American Board of Bionalysis as a High-complexity Clinical Laboratory Director/Clinical Consultant (HCLD/CC(ABB)).
Dr Ntrivalas has experience in laboratory accreditation. He has participated in committees, established by the Joint Commission, related to laboratory quality standards for flow cytometry and laboratory developed tests (LTDs). Dr Ntrivalas is a Medical Assessor for ISO 15189 and member of the Accreditation Council.